Skip to content

Comparing Medical Body Composition Analyzer Seca mBCA 555 With Seca mBCA 515

Clinical Accuracy Validation of the Medical Body Composition Analyzer Seca mBCA 555 in Comparison to Seca mBCA 515

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04030416
Enrollment
120
Registered
2019-07-24
Start date
2019-06-20
Completion date
2019-07-31
Last updated
2022-02-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bioelectrical Impedance Measurement of Healthy Adults

Keywords

mBCA 555

Brief summary

The mBCA 515 was compared to the gold standard methods MRI, DXA, ADP, D2O- and NaBr-dilution in previous clinical investigations (BCA-01, BCA-02, BCA-20) to generate prediction equations for calculating body composition (FFM, SMM, ECW, TBW and VAT) in different populations. Furthermore, normal ranges for body composition were generated based on the previous study BCA-03 conducted at the UKE. The mBCA 555 is a new body composition analyzer measuring bioimpedance in standing position developed by seca. In order to apply prediction equations and normal ranges from previous clinical investigations BCA-01, BCA-02, BCA-03 and BCA-20 to the new mBCA 555 it shall be compared to the mBCA 515.

Detailed description

The use of bioelectrical impedance analysis (BIA) is widespread both in healthy subjects and patients. BIA allows the determination of the fat-free mass (FFM), skeletal muscle mass (SMM), fat mass (FM), extracellular water (ECW) and total body water (TBW) when using appropriate population, age or pathology-specific BIA equations and established procedures. BIA equations are based on validation studies where BIA is compared with reference methods such as Air Displacement Plethysmography (ADP), Dual-Energy X-Ray Absorptiometry (DXA), Magnetic Resonance Imaging (MRI) and isotope dilution. The predicate device seca mBCA 515 was compared to the gold standard methods MRI, DXA, ADP, D2O- and NaBr-dilution in previous clinical investigations in Kiel (Germany) and New York City (USA) to generate prediction equations for calculating body composition (FFM, SMM, ECW, TBW and VAT) in different populations. Furthermore, normal ranges for body composition were generated in a previous study conducted at the University Hospital Hamburg-Eppendorf. The mBCA 555 is a new body composition analyzer measuring bioimpedance in standing position developed by seca. Primary objective is to test whether the mBCA 515 prediction equations can be applied to the new mBCA 555. If necessary, to proof substantial equivalence, prediction equations should be adjusted for the mBCA 555. Secondary objective is to compare Impedance, phase angle, reactance and resistance for different frequencies in order to clarify if normal ranges for BIVA and phase angle generated with the mBCA 515 need to be adjusted for the new mBCA 555. Bioimpedance was measured using the seca mBCA 555 and mBCA 515. Body height was measured using the seca 274.

Interventions

None listed

Sponsors

Seca GmbH & Co. Kg.
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum

Inclusion criteria

* male and female subjects, * 18 years and older, * subjects need to be able to sign the informed consent and privacy policy

Exclusion criteria

* acute disease * pregnancy * intake of diuretics * edema diagnosed by inspection and palpation of lower limbs * paralysis e.g. after a stroke * neurodegenerative diseases e.g. ALS * tumors in treatment * amputation * electronic implants e.g. pacemaker * probands who cannot provide an ICF by themselves * probands who might be dependent from the sponsor or the investigation site * current alcohol abuse * active prostheses * electronic life-support systems, e.g. artificial heart, artificial lung * portable electronic medical devices, e.g. ECG devices or infusion pumps * metallic implants

Design outcomes

Primary

MeasureTime frameDescription
SMM10minSkeletal muscle mass, bias of mBCA 555 in comparison to mBCA 515

Secondary

MeasureTime frameDescription
Phase Angle10 minutesPhase angle at 50 kHz, bias of mBCA 555 in comparison to mBCA 515

Other

MeasureTime frameDescription
R50RS5 minutesresistance right body side, 50 kHz, bias of mBCA 555 in comparison to mBCA 515
R5RS5 minutesresistance right body side, 5 kHz, bias of mBCA 555 in comparison to mBCA 515

Countries

Germany

Participant flow

Recruitment details

Subjects were recruited at the blood donor service of the Institute of Transfusion Medicine. All subjects needed to be suitable for blood donation according to Hämotherapie-Richtlinien nach §§ 12 a und 18 TFG, chapter 2.1.4. Blood donation was conducted after study examinations.

Participants by arm

ArmCount
Healthy Blood Donors
single arm study with healthy blood donors
119
Total119

Baseline characteristics

CharacteristicHealthy Blood Donors
Age, Continuous40.0 years
STANDARD_DEVIATION 13.6
Ethnicity (NIH/OMB)
Hispanic or Latino
NA Participants
Ethnicity (NIH/OMB)
Not Hispanic or Latino
NA Participants
Ethnicity (NIH/OMB)
Unknown or Not Reported
119 Participants
Sex: Female, Male
Female
57 Participants
Sex: Female, Male
Male
62 Participants
weight78.0 kg
STANDARD_DEVIATION 14.8

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 120
other
Total, other adverse events
0 / 120
serious
Total, serious adverse events
0 / 120

Outcome results

Primary

SMM

Skeletal muscle mass, bias of mBCA 555 in comparison to mBCA 515

Time frame: 10min

Population: healthy blood donors

ArmMeasureValue (MEAN)Dispersion
Healthy Blood DonorsSMM0.34 kgStandard Deviation 0.44
Secondary

Phase Angle

Phase angle at 50 kHz, bias of mBCA 555 in comparison to mBCA 515

Time frame: 10 minutes

Population: healthy blood donors

ArmMeasureValue (MEAN)Dispersion
Healthy Blood DonorsPhase Angle0.080 DegreeStandard Error 0.079
Other Pre-specified

R50RS

resistance right body side, 50 kHz, bias of mBCA 555 in comparison to mBCA 515

Time frame: 5 minutes

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Healthy Blood DonorsR50RS-1.9 OhmStandard Deviation 5.15
Other Pre-specified

R5RS

resistance right body side, 5 kHz, bias of mBCA 555 in comparison to mBCA 515

Time frame: 5 minutes

ArmMeasureValue (LEAST_SQUARES_MEAN)Dispersion
Healthy Blood DonorsR5RS-3.05 OhmStandard Deviation 6.12

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026